🎉 Exciting news at Imagenomix! We are delighted to announce that Mikhail Teverovskiy has joined us as our new Chief Technology Officer (CTO). 🚀 Mikhail brings over two decades of experience in software development and technology leadership, with a proven track record of driving innovation and building scalable, impactful solutions. His expertise perfectly aligns with our mission to revolutionize cancer diagnostics through advanced AI technologies. At Imagenomix, Mikhail will lead the development of our cutting-edge diagnostic platform, ensuring it delivers rapid, accurate, and accessible testing solutions to patients worldwide. 🌍💡 Please join me in welcoming Mikhail to our team as we embark on this transformative journey together. 🙌 #Leadership #Innovation #CancerDiagnostics #WelcomeToTheTeam
Imagenomix
Medical and Diagnostic Laboratories
New York, NY 221 followers
Cancer Genetics From Every Image
About us
At Imagenomix, we're not just in the business of technology; we're in the business of hope. Pioneering the intersection of innovation and medical precision, we specialize in delivering rapid cancer diagnostic results through advanced AI capabilities. Founded with a clear mission, our focus has always been on minimizing patient wait times and maximizing diagnostic accuracy. By serving patients globally, we're reducing the agonizing uncertainty that often comes with cancer diagnosis and ensuring that every individual receives timely information critical to their health journey. Our multidisciplinary team of AI experts, molecular pathologists, and oncologists is dedicated to transforming the face of healthcare. At Imagenomix, we believe in the power of swift and precise diagnostics, bringing clarity and direction to patients around the world.
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Pharma, NGS, AI, Cancer, Oncology, Lung, Brain, and Melanoma
Locations
-
Primary
New York, NY 10016, US
Employees at Imagenomix
Updates
-
🎉 Big news at Imagenomix! We’re thrilled to welcome Lizabeth Katsnelson, PhD, to our team as our new AI Data Scientist! 🚀. With her groundbreaking work in machine learning and cancer research—like identifying chromosome-specific aneuploidies linked to immune evasion in cancer—Lizabeth is a true innovator. Her Ph.D. from NYU School of Medicine and a track record of pushing boundaries in AI-driven diagnostics make her the perfect addition to our mission. At Imagenomix, we’re transforming cancer diagnostics with cutting-edge AI solutions, and Lizabeth will play a pivotal role in accelerating affordable, life-changing testing for patients globally. 🌍💡 Please join me in celebrating this exciting new chapter for Imagenomix and welcoming Lizabeth to our team! 🙌 Let’s shape the future of cancer care together. 💪 #AI #Innovation #CancerDiagnostics #WelcomeToTheTeam
-
Imagenomix Corp Selected for AWS Health Equity Initiative We are thrilled to announce that Imagenomix Corp has been selected for the prestigious AWS Health Equity Initiative. This recognition underscores our commitment to leveraging AI for rapid cancer mutation detection, enhancing healthcare accessibility and outcomes. For more details, please visit our official announcement here. https://lnkd.in/gwgmXH8A Thank you for your continued support as we strive to innovate and make a meaningful impact in the field of healthcare. — Imagenomix Team
-
Thank you to NYU Technology Opportunities & Ventures for hosting Imagenomix today! We appreciate your support, insights, and the discussion with vast opportunities and challenges as we launch our NYU based technology.
A great turnout today for our inaugural HealthVenture Exchange: Pitch & Problem Solving event! A huge thank you to our spotlight NYU startup Imagenomix for sharing their ideas and challenges with our attendees; to our panelists Maya Ber Lerner, Dr. Yin Aphinyanaphongs, and Dr. Whitney Snider, MD, MBA for their expert advice and feedback; and to all the attendees for their participation and innovative brainstorming! Keep an eye out for more HealthVenture Exchange events in the future!
-
Imagenomix reposted this
A great turnout today for our inaugural HealthVenture Exchange: Pitch & Problem Solving event! A huge thank you to our spotlight NYU startup Imagenomix for sharing their ideas and challenges with our attendees; to our panelists Maya Ber Lerner, Dr. Yin Aphinyanaphongs, and Dr. Whitney Snider, MD, MBA for their expert advice and feedback; and to all the attendees for their participation and innovative brainstorming! Keep an eye out for more HealthVenture Exchange events in the future!